Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Cellectar Biosciences, Inc.
Children's Oncology Group
Essen Biotech
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Australian & New Zealand Children's Haematology/Oncology Group
Adela, Inc